68. ClinGen Cancer Variant Interpretation (CVI): Updates and recommendations on the ClinGen/CGC/VICC Oncogenicity SOP. Ritter, D; Sonkin, D; Griffith, M; Griffith, O; Pavlick, D; Saliba, J; Seifi, M; Raca, G; Rosenbaum, J; Roy, S; Wagner, A; Kulkarni, S; Li, M; Plon, SE. Cancer genetics. 2024; 286:s22.

39. Modifying cancer variant interpretation guidelines for the curation of histone H3 variants: The 'next step' of the Cl. Satgunaseelan, L; Roy, S; Golem, S; Ji, J; Akkari, Y; Spiteri, E; Danos, A; Lin, W; Grisdale, C; Griffith, O; Griffith, M; Saliba, J; Meredith, D. Cancer genetics. 2024; 286:s12-s13.

Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Cournoyer, E; Ferrell, J; Sharp, S; Ray, A; Jordan, M; Dandoy, C; Grimley, M; Roy, S; Lorsbach, R; Merrow, AC; Nelson, A; Bartlett, A; Picarsic, J; Kumar, A. Haematologica: the hematology journal. 2024; 109:1137-1148.

PATH-46. A NOVEL POT1-TPD PRESENTATION: A GERMLINE POT1 MUTATION DISCOVERED IN A PATIENT WITH NEWLY DIAGNOSED POSTERIOR FOSSA EPENDYMOMA. Gilene, S; Raskin, S; Roy, S; Knapke, S. Neuro-Oncology. 2023; 25:v178.

Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report. Lee, TD; Aisner, DL; David, MP; Eno, CC; Gagan, J; Gocke, CD; Guseva, NV; Haley, L; Jajosky, AN; Jones, D; Wu, D; Xian, RR; Yohe, S; Kim, AS. Blood Advances. 2023; 7:4599-4607.

Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis. Milne, P; Bomken, S; Slater, O; Kumar, A; Nelson, A; Roy, S; Velazquez, J; Mankad, K; Nicholson, J; Yeomanson, D; Picarsic, J; Allen, C; Bigley, V; Collin, M. Blood Advances. 2023; 7:2171-2176.

Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology. Li, MM; Cottrell, CE; Pullambhatla, M; Roy, S; Temple-Smolkin, RL; Turner, SA; Wang, K; Zhou, Y; Vnencak-Jones, CL. The Journal of molecular diagnostics : JMD. 2023; 25:69-86.

Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists. Duncavage, EJ; Coleman, JF; de Baca, ME; Kadri, S; Leon, A; Routbort, M; Roy, S; Suarez, CJ; Vanderbilt, C; Zook, JM. The Journal of molecular diagnostics : JMD. 2023; 25:3-16.

Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing. Freeman, T; Taneja, C; Ohori, NP; Wald, AI; Skaugen, J; Yip, L; Kim, S; Ferris, RL; Nikiforova, MN; Roy, S; Nikiforov, YE. Endocrine-Related Cancer. 2022; 29:657-664.

112. ClinGen Somatic Cancer Variant Interpretation (CVI) committee and the Somatic Cancer expert panel process. Ritter, D; Duncavage, E; Elvin, J; Garrett, F; Griffith, OL; Griffith, M; Janeway, K; MacConaill, L; McCoy, M; Meric-Bernstam, F; Warner, J; Plon, S; Li, M; Kulkarni, S. Cancer genetics. 2022; 268:36.